These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 3811636)

  • 21. Nuclear DNA degradation in lymphocytes of patients with systemic lupus erythematosus.
    Compton LJ; Steinberg AD; Sano H
    J Immunol; 1984 Jul; 133(1):213-6. PubMed ID: 6725954
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-DNA Ig peptides promote Treg cell activity in systemic lupus erythematosus patients.
    Hahn BH; Anderson M; Le E; La Cava A
    Arthritis Rheum; 2008 Aug; 58(8):2488-97. PubMed ID: 18668553
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The prostaglandin-prostacyclin system and thrombocyte functions in patients with systemic lupus erythematosus].
    Pribytkov IuN; Poltyrev AS; Shilkina NP
    Ter Arkh; 1992; 64(12):44-8. PubMed ID: 1292132
    [No Abstract]   [Full Text] [Related]  

  • 24. Platelets stimulate thromboplastin synthesis in human endothelial cells.
    Johnsen UL; Lyberg T; Galdal KS; Prydz H
    Thromb Haemost; 1983 Apr; 49(2):69-72. PubMed ID: 6868014
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Bleeding due to platelet dysfunction as a presenting symptom of systemic lupus erythematosus].
    Bendayan D; Zeidman A; Mittelman M
    Harefuah; 1996 Feb; 130(4):229-30; 296. PubMed ID: 8675111
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased spontaneous but decreased mitogen-stimulated expression and excretion of interleukin 18 by mononuclear cells in patients with active systemic lupus erythematosus.
    Lee HT; Chen WS; Sun KH; Chou CT; Tsai CY
    J Rheumatol; 2009 Sep; 36(9):1910-6. PubMed ID: 19605669
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Platelets, growth factors, and vascular smooth-muscle cells in hypertension and diabetes.
    Mikhail N; Fukuda N; Tremblay J; Hamet P
    J Cardiovasc Pharmacol; 1993; 22 Suppl 6():S64-74. PubMed ID: 7508064
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nucleosomes are major T and B cell autoantigens in systemic lupus erythematosus.
    Bruns A; Bläss S; Hausdorf G; Burmester GR; Hiepe F
    Arthritis Rheum; 2000 Oct; 43(10):2307-15. PubMed ID: 11037891
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of serum from patients with systemic lupus erythematosus on the immune response of normal lymphocytes.
    Jarrett MP; Grayzel AI
    J Rheumatol; 1985 Feb; 12(1):81-6. PubMed ID: 3981521
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The pathogenetic role of immunoglobulin G from patients with systemic lupus erythematosus in the development of lupus pleuritis.
    Guo H; Leung JC; Chan LY; Chan TM; Lai KN
    Rheumatology (Oxford); 2004 Mar; 43(3):286-93. PubMed ID: 14623950
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Estrogen enhancement of anti-double-stranded DNA antibody and immunoglobulin G production in peripheral blood mononuclear cells from patients with systemic lupus erythematosus.
    Kanda N; Tsuchida T; Tamaki K
    Arthritis Rheum; 1999 Feb; 42(2):328-37. PubMed ID: 10025928
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patients with systemic lupus erythematosus show increased platelet activation and endothelial dysfunction induced by acute hyperhomocysteinemia.
    Tam LS; Fan B; Li EK; Thomas GN; Yim SF; Haines CJ; Tomlinson B
    J Rheumatol; 2003 Jul; 30(7):1479-84. PubMed ID: 12858444
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasminogen activator inhibitor-1 is associated with impaired endothelial function in women with systemic lupus erythematosus.
    Somers EC; Marder W; Kaplan MJ; Brook RD; McCune WJ
    Ann N Y Acad Sci; 2005 Jun; 1051():271-80. PubMed ID: 16126968
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Beta 2-glycoprotein I and anticardiolipin antibody binding to resting and activated cultured human endothelial cells.
    Hanly JG; Hong C; Issekutz A
    J Rheumatol; 1996 Sep; 23(9):1543-9. PubMed ID: 8877922
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Natural immune response involving anti-endothelial cell antibodies in normal and lupus pregnancy.
    Mendonca LL; Khamashta MA; Cuadrado MJ; Bertolaccini ML; Hughes GR
    Arthritis Rheum; 2000 Jul; 43(7):1511-5. PubMed ID: 10902753
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Thrombogenic properties of the vessel and their inhibition].
    Cazenave JP; Klein-Soyer C; Beretz A
    Nouv Rev Fr Hematol (1978); 1982; 24(3):167-71. PubMed ID: 6752880
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of peripheral blood lymphocytes from systemic lupus erythematosus patients on human bone marrow granulocyte precursor cells (colony-forming units in culture).
    Sugimoto M; Wakabayashi Y; Shiokawa Y; Takaku F
    Stem Cells (1981); 1982; 2(3):164-76. PubMed ID: 7163917
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic, immunologic, and immunohistochemical analysis of the programmed death 1/programmed death ligand 1 pathway in human systemic lupus erythematosus.
    Bertsias GK; Nakou M; Choulaki C; Raptopoulou A; Papadimitraki E; Goulielmos G; Kritikos H; Sidiropoulos P; Tzardi M; Kardassis D; Mamalaki C; Boumpas DT
    Arthritis Rheum; 2009 Jan; 60(1):207-18. PubMed ID: 19116915
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endothelium and arteriosclerosis.
    Harker LA; Schwartz SM; Ross R
    Clin Haematol; 1981 Jun; 10(2):283-96. PubMed ID: 7032778
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Abnormal signaling activity of phosphatidylinositol 3-kinase pathway in peripheral blood T cells from patients with systemic lupus erythematosus].
    Liang LQ; Zhan ZP; Xu HS; Yang XY; Ye YJ; Lian F; Qiu Q
    Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(29):2036-40. PubMed ID: 19080430
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.